Three-times-daily monotherapy with tacrolimus (FK 506) in kidney transplantation

International Journal of Urology

Volumn 3, Issue 3, 1996, Pages 180-183

  Ichikawa, Yasuji ^a   Hanafusa, Touru ^a   Kyo, Masahiro ^a   Fukunishi, Takanobu ^a   Nagano, Shunsuke ^a  

^a Hyogo Prefectural Nishinomiya Hospital   (Japan)

Author keywords

Immunosuppression; Kidney transplantation; Tacrolimus

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; DRUG BLOOD LEVEL; FEMALE; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PANCREATITIS; PEPTIC ULCER; PRIORITY JOURNAL;

EID: 0029904230     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.1996.tb00512.x     Document Type: Article

References (13)

1. Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramman R, Jain A. FK 506 for liver, kidney, and pancreas transplantation. Lancet 1989;2(8670):1000-1004.
2. Macleod AM, Thomson AW. FK 506: an immunosuppressant for the 1990s? Lancet 1991;337(8732):25-27.
3. Klintmalm GB. FK 506: an update. Clin Transplant 1994;8:207-210.
4. Shapiro R, Jordan M, Scantlebury V, Fung J, Jensen C, Tzakis A, McCauley J, Carroll P, Ricordi C, Demetris AJ, Mitchell S, Jain A, Iwaki Y, Kobayashi M, Reyes J, Todo S, Hakala TR, Simmons RL, Starzl TE. FK 506 in clinical kidney transplantation. Transplant Proc 1991;23:3065-3067.
5. Jordan ML, Shapiro R, Vivas CA, Scantlebury VP, Rhandhawa P, Carrieri G, McCauley J, Demetris AJ, Tzakis A, Fungs JJ, Simmons RL, Hakala TR, Starzl TE. FK 506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation 1994;57:860-865.
6. Japanese FK 506 Study Group. Morphopathological findings of renal allografts under FK506 therapy. Transplant Proc 1994;26:1933-1936.
7. Mor E, Sheiner PA, Schwartz ME, Emre S, Guy S, Miller CM. Reversal of severe FK 506 side effects by conversion to cyclosporine-based immunosuppression. Transplantation 1994;58:380-382.
8. Japanese FK506 Study Group. Japanese study of FK506 on kidney transplantation: Results of an early phase II study. Transplant Proc 1991;23:3071-3074.
9. Krentz AJ, Dmitrewski J, Mayer D, McMaster P, Buckels J, Dousset B, Cramb R, Smith JM, Nattrass M. Post-operative glucose metabolism in liver transplant recipients: a two-year prospective randomized study of cyclosporine versus FK 506. Transplantation 1994;57: 1666-1669.
10. Abu-Elmagd KM, Fung J, Draviam R, Shannon W, Jain A, Alessiani M, Takaya S, Venkataramanan R, Warty VS, Tzakis A, Todo S, Starzl TE. Four-hour versus 24-hour intravenous infusion of FK506 in liver transplantation. Transplant Proc 1991;23:2767-2770.
11. Japanese FK 506 Study Group. Japanese study of FK506 on kidney transplantation: results of late phase II study. Transplant Proc 1993;25:646-654.
12. Ochiai T, Ishibashi M, Fukao K, Takahashi K, Endo T, Yokoyama I, Uchida K, Oshima S, Takahara S, Morozumi K, Yamaguchi Y, Kyo M, Sonoda T, Takagi H, Ota K, Iwasaki Y, the Japanese FK506 Study Group. Japanese multi-center studies of FK506 in renal transplantation. Transplant Proc 1995;27:50-53.
13. Japanese FK 506 Study Group. Japanese study of FK 506 on kidney transplantation: the benefit of monitoring the whole blood FK 506 concentration. Transplant Proc 1991;23:3085-3088.